Mechanisms of regulatory capture: Testing claims of industry influence in the case of Vioxx
Mechanisms of regulatory capture: Testing claims of industry influence in the case of Vioxx
复制标题
监管捕获机制：以 Vioxx 为例检验行业影响力主张
DOI：
10.1111/rego.12531
复制
发表时间：
2023
影响因子：
3
通讯作者：
Heims E
中科院分区：
文献类型：
--
作者：
Heims E
本文对规制捕获的因果机制进行了系统的实证研究。它将过程追踪方法应用于vioxxdrug丑闻，该丑闻被广泛认为是捕获的结果。在此过程中，本文对当前文献中缺乏的监管捕获提供了强有力的实证分析。该分析聚焦于英国药品监管机构在许可和监督一种药物方面所扮演的角色。在2004年退出市场之前，这种药物曾导致数十万人心脏病发作。我们开发并系统地实施了三种捕获的因果机制，以研究万络的监管决策证据。通过对证据进行明确的理论和实证评估，我们发现通过旋转门、信息过载和共享文化框架捕获的程度是有限的。通过打开实证捕获研究的黑箱，本文强调了学者、媒体和政策制定者对监管捕获（错误）诊断的问题后果。
This paper presents a systematic empirical study of the causal mechanisms of regulatory capture. It applies process‐tracing methods to theVioxxdrug scandal that was widely regarded to be a result of capture. In doing so, this paper provides a robust empirical analysis of regulatory capture lacking in the current literature. The analysis focuses on the role of the UK drug regulator in licensing and monitoring a drug that caused hundreds of thousands of heart attacks before it was taken off the market in 2004. We develop and systemically operationalize three causal mechanisms of capture to study the evidence on regulatory decision‐making onVioxx. Through explicit theoretical and empirical evaluation of the evidence, we show that the degree of capture through the revolving door, information overload and shared cultural frameworks was limited. By opening the black‐box of empirical capture research, the paper highlights the problematic consequences of (mis‐)diagnosis of regulatory capture by scholars, the media, and policymakers.